Home › Funds › WOLVERINE ASSET MANAGEMENT LLC › LGND
WOLVERINE ASSET MANAGEMENT LLC position in LGND
LIGAND PHARMACEUTICALS INC · Health Care
WOLVERINE ASSET MANAGEMENT LLC reported holding 50,367,000 shares of LGND (LIGAND PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$84.8M, representing 1.62% of its reported portfolio and ranking #10 among its reported holdings. WOLVERINE ASSET MANAGEMENT LLC first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How WOLVERINE ASSET MANAGEMENT LLC's LGND position evolved
WOLVERINE ASSET MANAGEMENT LLC first disclosed a stake in LGND in Q3 2026 at 50,367,000 shares (US$84.8M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 50.37M | $84.80M | New |
About LGND and 13F data
LGND (LIGAND PHARMACEUTICALS INC) is a Health Care company. 51 other funds we track also report a position in LGND — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$139.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LGND
- CONGRESS ASSET MANAGEMENT CO 658.56K sh · $205.71M · Q3 2026
- Chicago Capital, LLC 551.23K sh · $172.19M · Q3 2026
- Stephens Investment Management Group LLC 446.14K sh · $139.36M · Q3 2026
- RICE HALL JAMES & ASSOCIATES, LLC 270.05K sh · $85.36M · Q2 2026
- GW&K Investment Management, LLC 241.76K sh · $75.52M · Q3 2026
- NEXT CENTURY GROWTH INVESTORS LLC 192.39K sh · $60.10M · Q3 2026
- Ranger Investment Management, L.P. 185.65K sh · $57.99M · Q3 2026
- ASHFORD CAPITAL MANAGEMENT INC 170.24K sh · $53.81M · Q2 2026
- Private Capital Management, LLC 166.02K sh · $52.48M · Q2 2026
- Granahan Investment Management, LLC 147.23K sh · $46.54M · Q2 2026
- Penn Capital Management Company, LLC 98.75K sh · $30.88M · Q3 2026
More on WOLVERINE ASSET MANAGEMENT LLC
FAQ
How long has WOLVERINE ASSET MANAGEMENT LLC held LGND?
WOLVERINE ASSET MANAGEMENT LLC has disclosed LGND holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is WOLVERINE ASSET MANAGEMENT LLC's current position in LGND?
As of Q3 2026, WOLVERINE ASSET MANAGEMENT LLC holds 50.37M shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $84.80M, representing 1.62% of its reported portfolio and ranking #10.
Has WOLVERINE ASSET MANAGEMENT LLC been buying or selling LGND?
In the latest 13F filing (Q3 2026), WOLVERINE ASSET MANAGEMENT LLC newly opened its position in LGND.
Which other funds hold LGND?
Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, Stephens Investment Management Group LLC, among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.